Taysha Gene Therapies Inc. (TSHA), a pivotal-stage gene therapy company, has a couple of clinical, regulatory and preclinical milestones lined up for the remainder of this year. The company has 26 AAV-based gene therapies under development for the treatment of monogenic diseases of the central nervous system...
from RTT - Top Story https://ift.tt/2XFm2Qi
via IFTTT
from RTT - Top Story https://ift.tt/2XFm2Qi
via IFTTT
Comments
Post a Comment